Therapeutic applications: natural killer cells in the clinic

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2013, Issue , 2013, Pages 247-253

  Miller, Jeffrey S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IL15 PROTEIN, HUMAN; IL2 PROTEIN, HUMAN; INTERLEUKIN 15; INTERLEUKIN 2;

ADOPTIVE TRANSFER; ANIMAL; CELL TRANSFORMATION; CLINICAL TRIAL (TOPIC); HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REGULATORY T LYMPHOCYTE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CLINICAL TRIALS AS TOPIC; GPI-LINKED PROTEINS; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, IGG; T-LYMPHOCYTES, REGULATORY;

EID: 84905970560     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2013.1.247     Document Type: Review

References (0)